Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen, Millipore, Reneuron Group

Premium
Qiagen this week introduced its FlexiPlate siRNA line of customizable siRNA sets for specified genes and siRNA controls. Customers can order any set of siRNAs via Qiagen’s GeneGlobe web portal, and the selected siRNA sets are delivered in standard 96-well plates, according to the company.
 

 
Millipore this week announced the launch of the ReNcell product line, “the only human immortalized neural somatic stem cell lines on the market,” according to the company.
 
ReNcell consists of two cell lines of immortalized human neural progenitor cells and media for maintenance, expansion, and freezing. The cell lines are available either individually or as a kit. Millipore said the product is a result of a distribution agreement signed earlier this year with Reneuron Group.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.